ZNTL

1.3600.00%
JM

Julie M. Eastland

CEO, President & Director

Ms. Julie M. Eastland, M.B.A., is Advisor of Trio Pharmaceuticals Inc. Ms. Julie M. Eastland is CEO, President & Director of Zentalis Pharmaceuticals, Inc. from November 13, 2024. Ms. Eastland joined the Zentalis Pharmaceuticals, Inc. on November 12, 2024. She serves as Independent Director of Lantheus Holdings, Inc. since September 3, 2024. She served as Chief Operating Officer and Chief Financial Officer at Recode Therapeutics, Inc. since October 2020 until November 2021. She serves as Director at Seismic Therapeutic, Inc. since September 2024. She was Director of CalciMedica, Inc. until March 20, 2023. She served as the President and Chief Executive Officer at Harpoon Therapeutics, Inc. since November 2021 and was its Director since October 2018. She served as Secretary at Harpoon Therapeutics, Inc. She served as a Director of Graybug Vision, Inc. until February 2023. She previously served as chief financial officer and chief business officer of Rainier Therapeutics from September 2010 to January 2020. She served as the Chief Financial Officer and Secretary at Cascadian Therapeutics, Inc. from August 17, 2010 and October 2010 to March 9, 2018 respectively and also its Chief Business Officer from March 29, 2017 to March 9, 2018. Ms. Eastland served as a Vice President of Corporate Development at Cascadian Therapeutics, Inc. since August 17, 2010 until March 29, 2017 and served as its Principal Accounting Officer. She served as the Chief Financial Officer and Vice President of Finance & Administration at VLST Corporation from January 2006 to September 2010 and also served as its vice president of operations, where she had been responsible for strategic planning, long-range planning, financial analysis and project management. She served as a Vice President of Strategic Planning at Dendreon Corp. from October 2000 to October 2005. She served at Dendreon Corporation from 2000 to 2005, where she held various finance positions. Prior to Dendreon, Ms. Eastland was the Controller at Amgen, a biopharmaceutical company, from March 1996 to April 1998. Ms. Eastland served as an Area Finance Manager of Colorado operations and an Assistant Controller of Amgen BioPharma at Amgen, Inc. from 1996 to 1998. She served as Director of Finance at Biovail Corporation, Director of finance & planning at Encore Media Group, international finance & business Manager of Science Magazine and financial Manager of Discovery Channel. She served as Senior Director and Director of Finance of Dendreon. She has expertise in professional and corporate industries, specializing in developing and implementing strategic plans into operational successes. She served as Independent Director of Pascal Biosciences Inc. since July 16, 2018 until 2021. Ms. Eastland served as a Director of CG Therapeutics, Inc. She holds an MBA from Heriot-Watt University of the Edinburgh University Management School and a B.S. in finance from the Colorado State University. She was Independent Director of Dynavax Technologies Corporation from July 2020 to June 2025.

Positions